インフォショップ ホームへ 株式会社グローバルインフォメーション
サイトマップ
その他のカテゴリ

商品カタログ

医療/バイオの調査資料販 MEDINFO.JP

バイオシミラー特集
バイオシミラー特集ページ バイオシミラーに関連したレポートを紹介致します。

Global Pharmaceuticals Research & Manufacturing 公式サイト

Translational Cancer Medicine 公式サイト

Outsourcing Asia Summit 2009 公式サイト

Global Healthcare Congress 2009 公式サイト

BioMedical Asia 2009 公式サイト

China 2009 Pharmaceutical R&D Summit 公式サイト

Drug Discovery & Development of Innovative Therapeutics Japan 2009 公式サイト

Drug Discovery & Development of Innovative Therapeutics 2009 公式サイト
English Korean Chinese
【 英文市場調査報告書 】

糖尿病と妊娠

Diabetes and Pregnancy - Delivering Improved Outcomes

商品コード : 20753 Datamonitor
出版日 : 2004/06
発行 : Datamonitor
電話でのお問い合わせ
価格情報
概要 原文目次
※この商品は英文にてご提供いたします。

Introduction

About one in 100 women of childbearing age have diabetes before pregnancy (pre-existing diabetes). Another 3-5% develop diabetes during pregnancy (gestational diabetes). While diabetes poses some risks in pregnancy, advances in healthcare have greatly improved the outlook for these pregnancies. However, untreated or poorly controlled gestational diabetes can seriously harm the fetus.

Scope of this report

  • Review of therapeutic approaches to gestational diabetes mellitus and pre-existing diabetes during pregnancy to protect the health of mother & baby
  • Overview of screening and diagnosis guidelines

Research and analysis highlights

The prevalence of congenital anomalies among children of diabetic women is much higher compared to non-diabetic women. The frequency of malformations correlates with the degree of maternal glycemic control. Their prevalence may be reduced by normalization of blood glucose and the maintenance of normal glycemic control throughout the pregnancy.

Key reasons to read this report

  • Get insight in the current therapeutic approaches used to treat women with gestational and pre-existing diabetes during pregnancy
  • Understand the effect of diabetes in pregnancy outcomes and gauge the impact of diabetic complications in the treatment of pregnant women

ABOUT DATAMONITOR HEALTHCARE

About the Cardiovascular pharmaceutical analysis team

EXECUTIVE SUMMARY

Introduction
Scope and coverage of the Brief
Key findings about the topic

GESTATIONAL DIABETES MELLITUS

Definition
Screening and diagnosis
Prevalence
Pathophysiology
The mother
The fetus
Management of GDM
Antepartum management
Nutrition therapy
Monitoring effectiveness of therapy
Intensification of treatment
Obstetric management
Assessment of fetal wellbeing
Timing and mode of delivery
Management after pregnancy
The mother
The child

MANAGEMENT OF PREGNANT DIABETICS

Preconceptional metabolic control and congenital malformations
Management of pregnant diabetic women without complications
Nutrition recommendations
Exercise
Insulin
Hypoglycemia
Ketosis
Management of pregnant diabetic women with vascular complications
Coronary artery disease
Diabetic nephropathy
Retinopathy

APPENDIX

Bibliography
Disclaimer

List of Tables

Table 1: Diagnostic criteria for GDM
Table 2: Glucose targets for antepartum management of GDM
Table 3: Estimated prevalence of CAD in diabetics in the seven major markets, 2003
Table 4: Estimated prevalence of diabetic nephropathy in the seven major markets, 2003
Table 5: Changes in kidney structure and function in diabetic nephropathy
Table 6: Perinatal outcome of patients with diabetic nephropathy
Table 7: Estimated prevalence of diabetic retinopathy in the seven major markets, 2003

List of Figures

Figure 1: Classification of patients at risk of developing GDM
Figure 2: Recommended screening for patients at risk of developing GDM
Figure 3: White's classification of diabetes in pregnancy
概要 原文目次
※この商品は英文にてご提供いたします。
【 英文市場調査報告書 】
糖尿病と妊娠
Diabetes and Pregnancy - Delivering Improved Outcomes
出版日 : 2004/06
電話でのお問い合わせ
この商品について問い合わせる
この商品のサンプル(抜粋)を依頼する
価格

※ドル建て価格の商品のお支払いは、為替レート (TTS: 94.69) 換算による円建てのご請求書にて承ります。

US $ 1,900 換算 -> ¥ 179,911 (税抜) PDF by E-mail (Single User License)
商品コード : 20753
関連カテゴリ : 糖尿病
関連する商品をキーワードで検索する